JP2023542737A5 - - Google Patents

Info

Publication number
JP2023542737A5
JP2023542737A5 JP2023519633A JP2023519633A JP2023542737A5 JP 2023542737 A5 JP2023542737 A5 JP 2023542737A5 JP 2023519633 A JP2023519633 A JP 2023519633A JP 2023519633 A JP2023519633 A JP 2023519633A JP 2023542737 A5 JP2023542737 A5 JP 2023542737A5
Authority
JP
Japan
Application number
JP2023519633A
Other languages
Japanese (ja)
Other versions
JP2023542737A (ja
JPWO2022072446A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052579 external-priority patent/WO2022072446A1/en
Publication of JP2023542737A publication Critical patent/JP2023542737A/ja
Publication of JP2023542737A5 publication Critical patent/JP2023542737A5/ja
Publication of JPWO2022072446A5 publication Critical patent/JPWO2022072446A5/ja
Pending legal-status Critical Current

Links

JP2023519633A 2020-09-29 2021-09-29 ネコ科動物抗体バリアント Pending JP2023542737A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063084693P 2020-09-29 2020-09-29
US63/084,693 2020-09-29
PCT/US2021/052579 WO2022072446A1 (en) 2020-09-29 2021-09-29 Feline antibody variants

Publications (3)

Publication Number Publication Date
JP2023542737A JP2023542737A (ja) 2023-10-11
JP2023542737A5 true JP2023542737A5 (https=) 2024-10-02
JPWO2022072446A5 JPWO2022072446A5 (https=) 2024-10-02

Family

ID=78599139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519633A Pending JP2023542737A (ja) 2020-09-29 2021-09-29 ネコ科動物抗体バリアント

Country Status (15)

Country Link
EP (2) EP4221744A1 (https=)
JP (1) JP2023542737A (https=)
KR (1) KR20230091914A (https=)
CN (1) CN116457369A (https=)
AR (1) AR123645A1 (https=)
AU (1) AU2021352395A1 (https=)
CA (1) CA3195049A1 (https=)
CL (2) CL2023000914A1 (https=)
CO (1) CO2023004107A2 (https=)
EC (1) ECSP23030307A (https=)
IL (1) IL301414A (https=)
MX (1) MX2023003694A (https=)
PE (1) PE20240110A1 (https=)
TW (3) TWI880316B (https=)
WO (1) WO2022072446A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR123645A1 (es) 2020-09-29 2022-12-28 Zoetis Services Llc Variantes de anticuerpos felinos

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US5698762A (en) 1994-12-09 1997-12-16 Dauerman; Leonard Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons
US20030031671A1 (en) 2001-08-01 2003-02-13 Sydney Welt Methods of treating colon cancer utilizing tumor-specific antibodies
KR20070057839A (ko) 2004-08-19 2007-06-07 제넨테크, 인크. 변경된 이펙터 기능을 갖는 폴리펩티드 변이체
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
DK1817340T3 (da) 2004-11-12 2012-08-13 Xencor Inc Fc-varianter med ændret binding til fcrn
RU2529951C2 (ru) * 2007-12-26 2014-10-10 Ксенкор, Инк. ВАРИАНТЫ Fc С ИЗМЕНЕННЫМ СВЯЗЫВАНИЕМ C FcRn
US9505829B2 (en) 2010-08-19 2016-11-29 Zoetis Belgium S.A. Anti-NGF antibodies and their use
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
EP2859018B1 (en) 2012-06-06 2021-09-22 Zoetis Services LLC Caninized anti-ngf antibodies and methods thereof
WO2019113123A1 (en) * 2017-12-04 2019-06-13 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
CN113194984A (zh) * 2018-10-18 2021-07-30 金德雷德生物科学股份有限公司 兽用的与新生儿Fc受体(FcRn)结合改变的Fc变体
CN113227134A (zh) * 2018-12-05 2021-08-06 株式会社梅花治疗 抗体的Fc区变体
WO2021212084A1 (en) * 2020-04-17 2021-10-21 Zoetis Services Llc Feline antibody variants
AR123645A1 (es) 2020-09-29 2022-12-28 Zoetis Services Llc Variantes de anticuerpos felinos

Similar Documents

Publication Publication Date Title
JP2023542737A5 (https=)
CN305530723S (https=)
CN306319826S (https=)
CN305536763S (https=)
CN306053484S (https=)
CN306041340S (https=)
CN306038946S (https=)
CN305536709S (https=)
CN306037862S (https=)
CN306035655S (https=)
CN306599573S (https=)
CN305699323S (https=)
CN306073255S (https=)
CN305535738S (https=)
CN306114910S (https=)
CN306115366S (https=)
CN306137834S (https=)
CN305534949S (https=)
CN306149315S (https=)
CN306150105S (https=)
CN306601226S (https=)
CN306602033S (https=)
CN306150607S (https=)
CN306153933S (https=)
CN305534945S (https=)